Biotechnology News

IRVINE, Calif., Feb. 08, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) announces that it will release financial results for the three months and full year ended December 31, 2015...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} BIONOR PHARMA ASA PRESS RELEASE Notice of...

Read the full announcement in PDF format....

Læs hele meddelelsen i pdf format....

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Communiqué de Presse Montrouge,...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Press Release Montrouge, France,...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Étude de Phase I multicentrique,...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Multicenter, open-label,...

Valneva signe un nouvel accord de R&D avec GlaxoSmithKline sur sa lignée cellulaire EB66® Valneva fournira des prestations de recherche pour des vaccins contre le virus de la grippe développés...

Valneva Signs New R&D Collaboration with GlaxoSmithKline for the EB66® Cell Line  Valneva to supply process development services for EB66®-based Influenza vaccines Advanced Development program...